Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/04/066294
CTRI/2024/04/066294
Not yet recruiting
Phase 4

Comparative evaluation of recombinant human epidermal growth factor and insulin like growth factor-1 coated membranes in the management of isolated millers class 1 gingval recession defects. - NI

Sibar Institute of Dental Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Sibar Institute of Dental Sciences
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sibar Institute of Dental Sciences

Eligibility Criteria

Inclusion Criteria

  • •1\.Age group 18\-45 years.
  • •2\.Subjects who are apparently healthy.
  • •3\.Presence of Miller’s Class I gingival recession.
  • •4\.Width of keratinized gingiva (KGW) \=2 mm.
  • •5\.Presence of identifiable Cemento\-Enamel Junction (CEJ).
  • •6\.Subjects who are willing to give informed consent.

Exclusion Criteria

  • •1\.Subjects under medication.
  • •2\.Wasting diseases.
  • •3\.Presence of caries, furcations involvement in isolated gingival recessions.
  • •4\.Pregnant or lactating females.
  • •5\.Any form of Tobacco users.
  • •6\.Subjects with Tooth mobility.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparison of topical recombinant human epidermal growth factor versus aloe vera gel in combination with ablative 10,600-nm carbon dioxide fractional laser for the treatment of striae alba: A randomized, double-blind trialStriae albastriae alba&#44recombinant&#45human epidermal growth factor&#44fractional carbon dioxide laser
TCTR20180610001Thammasat University24
Not yet recruiting
Phase 4
Healing of mouth soft tissues using topically applied gel.
CTRI/2023/01/049177OFFICE OF DGDS
Completed
Not Applicable
The clinical benefit of topical moisturizers in xerosis patientDiseases of the skin and subcutaneous tissue
KCT0001508Samsung Medical Center80
Not yet recruiting
Phase 4
To compare the clinical outcome of topical recombinant human epidermal growth factor and conventional saline dressing in management of diabetic foot ulcers - a randomised controlled trial
CTRI/2024/06/068922Aarupadai veedu medical College and hospital
Not yet recruiting
Phase 3
Effect of topical recombinant human epidermal growth factor on chronic diabetic ulcer compared with conventional saline dressing
CTRI/2024/05/067239Dr A Sneha Daffodil